RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1903-1920

  Nazli, Caner ^a   Ergenc, Tugba Ipek ^a   Yar, Yasemin ^a   Acar, Havva Yagci ^a   Kizilel, Seda ^a  

^a KOÇ UNIVERSITY   (Turkey)

Author keywords

Agglomeration; Nanoparticle encapsulation; PEG hydrogel; Surface initiated photopolymerization

Indexed keywords

ARGINYLGLYCYLASPARTYLSERINE; MACROGOL; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG; ARGINYL GLYCYL ASPARTYL SERINE; ARGINYL-GLYCYL-ASPARTYL-SERINE; BIOMATERIAL; IRON; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY TEST; FREEZE DRYING; HELA CELL; HYDROGEL; INFRARED SPECTROSCOPY; INTRACELLULAR TRANSPORT; MATERIAL COATING; PARTICLE SIZE; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS; UTERINE CERVIX CANCER; ZETA POTENTIAL; ACTIVE TRANSPORT; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; NANOMEDICINE; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; X RAY DIFFRACTION;

BIOLOGICAL TRANSPORT, ACTIVE; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; HELA CELLS; HUMANS; HYDROGELS; IRON; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; NANOMEDICINE; OLIGOPEPTIDES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84866748952     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29442     Document Type: Article

References (60)

1. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60(11):1252-1265.
2. Mahmoudi M, Simchi A, Imani M. Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications. J Iran Chem Soc. 2010;7(Suppl 1):S1-S27.
3. Ai J, Biazar E, Jafarpour M, et al. Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine. 2011;6:1117-1127.
4. Saltan N, Kutlu HM, Hür D, Işcan A, Say R. Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid. Int J Nanomedicine. 2011;6:477-484.
5. Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine. 2011;6:787-794.
6. Oh JK. Iron oxide-based superparamagnetic polymeric nanomaterials: design, preparation, and biomedical application. Prog Polym Sci. 2011; 36(1):168-189.
7. Mou Y, Hou Y, Chen B, et al. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomedicine. 2011;6:2633-2640.
8. Xie Y, Zeng P, Siegel RA, Wiedmann TS, Hammer BE, Longest PW. Magnetic deposition of aerosols composed of aggregated superparamagnetic nanoparticles. Pharm Res. 2010;27(5):855-865.
9. Hu F, Neoh KG, Cen L, Kang ET. Cellular response to magnetic nanoparticles "PEGylated" via surface-initiated atom transfer radical polymerization. Biomacromolecules. 2006;7(3):809-816.
10. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18): 3995-4021.
11. Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32(8):2183-2193.
12. Lee HY, Lim NH, Seo JA, et al. Preparation and magnetic resonance imaging effect of polyvinylpyrrolidone-coated iron oxide nanoparticles. J Biomed Mater Res B Appl Biomater. 2006;79(1):142-150.
13. Acar HYC, Garaas RS, Syud F, Bonitatebus P, Kulkarni AM. Superparamagnetic nanoparticles stabilized by polymerized PEGylated coatings. J Magn Magn Mater. 2005;293(1):1-7.
14. Tong S, Hou S, Zheng Z, Zhou J, Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 2010;10(11):4607-4613.
15. Barbucci R. Hydrogels: Biological Properties and Applications. New York, NY: Springer; 2009.
16. Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials. 2010;31(17):4639-4656.
17. Peng XH, Qian X, Mao H, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine. 2008;3(3):311-321.
18. Kizilel S, Pérez-Luna VH, Teymour F. Photopolymerization of poly(ethylene glycol) diacrylate on eosin-functionalized surfaces. Langmuir. 2004;20(20):8652-8658.
19. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (Lond). 2007;2(1):23-39.
20. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 2002;23(22):4315-4323.
21. Cruise GM, Hegre OD, Lamberti FV, et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999; 8(3): 293-306.
22. Meenach SA, Hilt JZ, Anderson KW. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 2010;6(3):1039-1046.
23. Kizilel S, Scavone A, Liu X, et al. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion. Tissue Eng Part A. 2010;16(7):2217-2228.
24. Xiang Y, Peng Z, Chen D. A new polymer/clay nano-composite hydrogel with improved response rate and tensile mechanical properties. Eur Polym J. 2006;42(9):2125-2132.
25. Schexnailder P, Schmidt G. Nanocomposite polymer hydrogels. Colloid Polym Sci. 2009;287(1):1-11.
26. Meenach SA, Anderson KW, Hilt JZ. Hydrogel nanocomposites: biomedical applications, biocompatibility, and toxicity analysis. In: Webster TJ, editor. Safety of Nanoparticles: From Manufacturing to Medical Applications, 1st ed. New York, NY: Springer; 2009:131-158.
27. Degirmenbasi N, Kalyon DM, Birinci E. Biocomposites of nanohydroxyapatite with collagen and poly(vinyl alcohol). Colloids Surf B Biointerfaces. 2006;48(1):42-49.
28. Frimpong RA, Fraser S, Hilt JZ. Synthesis and temperature response analysis of magnetic-hydrogel nanocomposites. J Biomed Mater Res A. 2007;80(1):1-6.
29. Meenach SA, Anderson AA, Suthar M, Anderson KW, Hilt JZ. Biocompatibility analysis of magnetic hydrogel nanocomposites based on poly(N-isopropylacrylamide) and iron oxide. J Biomed Mater Res A. 2009;91(3):903-909.
30. Okada M, Yasuda S, Kimura T, et al. Optimization of amino group density on surfaces of titanium dioxide nanoparticles covalently bonded to a silicone substrate for antibacterial and cell adhesion activities. J Biomed Mater Res A. 2006;76(1):95-101.
31. Kizilel S, Sawardecker E, Teymour F, Pérez-Luna VH. Sequential formation of covalently bonded hydrogel multilayers through surface initiated photopolymerization. Biomaterials. 2006;27(8):1209-1215.
32. Kizilel S, Pérez-Luna VH, Teymour F. Mathematical model for surfaceinitiated photopolymerization of poly(ethylene glycol) diacrylate. Macromol Theor Simul. 2006;15(9):686-700.
33. Kizilel S, Pérez-Luna VH, Teymour F. Modeling of PEG hydrogel membranes for biomedical applications. Macromol React Eng. 2009; 3(5-6):271-287.
34. Kizilel S. Mathematical model for microencapsulation of pancreatic islets within a biofunctional PEG hydrogel. Macromol Theor Simul. 2010;19(8-9):514-531.
35. Zhang C, Jugold M, Woenne EC, et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res. 2007;67(4):1555-1562.
36. Kessler T, Bieker R, Padró T, et al. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature. Clin Cancer Res. 2005;11(17):6317-6324.
37. Kim HC, Lee SK, Lee SW, Jeong SW. A reactive polythiophene for protein immobilization. Polym Adv Technol. 2009;20(3):298-302.
38. Porjazoska A, Yilmaz OK, Baysal K, et al. Synthesis and characterization of poly(ethylene glycol)-poly(D, L-lactide-co-glycolide) poly(ethylene glycol) tri-block co-polymers modified with collagen: a model surface suitable for cell interaction. J Biomater Sci Polym Ed. 2006;17(3): 323-340.
39. Liao Z, Wang H, Lv R, et al. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells. Langmuir. Epub February 22, 2011.
40. Váró G, Brown LS, Needleman R, Lanyi JK. Binding of calcium ions to bacteriorhodopsin. Biophys J. 1999;76(6):3219-3226.
41. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience. 2004;3(1):66-73.
42. Ma HL, Qi XR, Maitani Y, Nagai T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm. 2007;333(1-2):177-186.
43. Park JY, Daksha P, Lee GH, Woo S, Chang Y. Highly water-dispersible PEG surface modified ultra small superparamagnetic iron oxide nanoparticles useful for target-specific biomedical applications. Nanotechnology. 2008;19(36):365603.
44. Mikhaylova M, Kim DK, Berry CC, et al. BSA immobilization on amine-functionalized superparamagnetic iron oxide nanoparticles. Chem Mater. 2004;16(12):2344-2354.
45. Stuart B. Infrared Spectroscopy: Fundamentals and Applications. Hoboken, NJ: John Wiley & Sons; 2004.
46. Xie J, Chen K, Lee HY, et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am Chem Soc. 2008;130(24):7542-7543.
47. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res. 1998;39(2):266-276.
48. Moore A, Marecos E, Bogdanov A Jr, Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 2000;214(2):568-574.
49. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23(7):1553-1561.
50. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600-1603.
51. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284-304.
52. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319-2331.
53. Ge Y, Zhang Y, Xia J, et al. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids Surf B Biointerfaces. 2009;73(2):294-301.
54. Wu X, Tan Y, Mao H, Zhang M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine. 2010;5:385-399.
55. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4(1):26-49.
56. Koo YE, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev. 2006;58(14):1556-1577.
57. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm. 2008;5(2):316-327.
58. Silva AC, Oliveira TR, Mamani JB, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine. 2011;6:591-603.
59. Rodríguez-Luccioni H, Latorre-Esteves M, Méndez-Vega J, et al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int J Nanomedicine. 2011;6:373-380.
60. Hofmann-Amtenbrink M, Hofmann H. Superparamagnetic nanoparticles for biomedical applications. In: Tan MC, editor. Nanostructured Materials for Biomedical Applications, 1st ed. Kerala, India: Transworld Research Network; 2009.